Fundraising FoxSaliogen Therapeutics
Burlington, US · Founded 2020 · Delaware corporation
Find your way into Saliogen Therapeutics
Sign up to see every warm intro you have to Saliogen Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Saliogen Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SalioGen Therapeutics was a genetic medicine company. The company is no longer operating.
Founders & leadership
SN
Sukumar NagendranNamed on SEC filing
SS
Sean StalfortNamed on SEC filing
JH
Joseph HigginsNamed on SEC filing
RT
Raymond TabibiazarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$152.2M disclosed across 2 rounds · 2021
▶$132.2MraisedApr 2022 · 24 investors · BiotechnologyRule 506(b)
▶$132.2MraisedApr 2022 · 24 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sukumar NagendranDirector
- Joseph HigginsExecutive Officer, Director
- Craig GordonDirector
- Raymond TabibiazarExecutive Officer, Director
- Sean StalfortDirector
- Offering amount
- $132.2M
- Amount sold
- $132.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$20MraisedFeb 2021 · 3 investors · BiotechnologyRule 506(b)
▶$20MraisedFeb 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sukumar NagendranDirector
- Sean StalfortDirector
- Joseph HigginsExecutive Officer, Director
- Raymond TabibiazarExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $20M
- Placement agents
- BTIG, LLC
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Biogen IdecBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
SolugenSolugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.
SoleySoley Therapeutics develops proprietary imaging, AI, and automation technology to analyze cellular responses to stress and drug exposure, enabling the discovery of novel medicines and therapeutic mechanisms.
PrecigenPrecigen is a biopharmaceutical company developing gene and cell therapies, including PAPZIMEOS (zopapogene imadenovec-drba), an FDA-approved immunotherapy for adults with recurrent respiratory papillomatosis. The company focuses on immuno-oncology and immunotherapy treatments delivered via subcutaneous injection.
WugenAllotera (formerly Wugen) develops allogeneic T-cell therapies. The company focuses on cell and gene therapy approaches for treating disease.
Companies working in the same space as Saliogen Therapeutics.
Frequently asked questions
- What does Saliogen Therapeutics do?
- SalioGen Therapeutics was a genetic medicine company. The company is no longer operating.
- How much funding has Saliogen Therapeutics raised?
- Saliogen Therapeutics has disclosed $152.2M raised across 2 rounds.
- Where is Saliogen Therapeutics headquartered?
- Saliogen Therapeutics is headquartered in Burlington, US.